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Acute bacterial meningitis in infancy is a medical emergency which requires prompt diagnosis and treatment. It is associated with significant morbidity and mortality despite 
advances in the treatment [1-3]. The common etiological agents of 
pyogenic meningitis reported from India include Staphylococcus 
aureus and Streptococcus species among Gram-positive bacilli and 
Escherichia coli, Klebsiella pneumonia, and Pseudomonas aeruginosa 
among the Gram-negative bacilli [2,3]. Salmonella is a rare cause of 
bacterial meningitis, and limited reports suggest high morbidity and 
mortality rates among infants [4-6]. We present a case of Salmonella 
typhimurium meningitis in an immunocompetent infant.
CASE REPORT
A 10-month-old male infant was brought to the pediatric 
emergency department of with complaints of fever with chills 
and loose motions for 3 days, vomiting, reduced oral acceptance 
and irritability of 1-day duration. There was no history of seizures 
or any abnormal movements. He was born by full-term normal 
vaginal delivery to a primigravida mother. His birth weight was 
2.6 kg and cried immediately after delivery with no antenatal, 
intranatal, and postnatal complications. The child was exclusively 
breastfed, and complementary feedings were started at 6 months 
of age. He was immunized and had attained milestones as per age.
On initial examination, he was febrile (39.5°C) and had 
respiratory rate of 32/min, heart rate of 120 beats/min, blood 
pressure of 92/60 mmHg, capillary refill time of 2 s, and weight of 
7.6 kg. The central nervous system examination revealed that the 
child was irritable, anterior fontanelle was full and had hypertonia 
with brisk deep tendon reflexes, neck rigidity and positive Kerning’s 
and Brudzinski’s sign. Bilateral symmetrical chest movements 
were present with no organomegaly and normal bowel sounds.
Initial blood investigations revealed anemia (hemoglobin 
[Hb]: 10 g/dL) with normal total and differential white blood 
cell (WBC) and platelet counts (Table 1). Liver and kidney 
function tests were normal and rapid test for malaria was 
negative. Samples were sent for blood culture and sensitivity 
testing. A lumbar puncture (LP) was done which revealed turbid 
cerebrospinal fluid (CSF) with total WBC count of 400 cells/mm3 
with 85% polymorphs. The CSF protein was elevated to 200 mg/
dl, and sugar was reduced to 19 mg/dl. The child was started on 
IV ceftriaxone (100 mg/kg/day) along with intravenous fluids.
The CSF gram stain smear showed pus cells with a few 
Gram-negative bacilli. CSF culture grew S. typhimurium. 
The isolate was susceptible to ampicillin, ceftriaxone, 
imipenem, meropenem and ciprofloxacin by Kirby Bauer disc 
diffusion method, and minimum inhibitory concentrations 
(MICs) confirmed by Vitek II automated system. Blood 
culture also grew S. typhimurium with similar antibiogram. 
Other investigations including typhidot (immunoglobulin 
M), widal, and urine culture were negative. Further work-up 
for underlying immunodeficiency disorders was negative 
including normal immunoglobulin levels and negative enzyme-
linked immunosorbent assay for HIV. His serum calcium was 
7.1 mg/dl, and sickling test was negative. Ultrasonography 
(USG) of abdomen revealed mild hepatosplenomegaly.
Meanwhile, intravenous ciprofloxacin (15 mg/kg/day) was 
added after getting the culture reports. The child continued to have 
high-grade fever; although there was an improvement in irritability 
and meningeal signs over next 5 days. Repeat hemogram revealed 
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moderate anemia (Hb: 6.9 g/dL) and leukocytosis (total leukocyte 
count: 26,700/mm3) with neutrophilia (polymorphs 78%). Blood 
cultures sent on day 5 of admission again grew S. typhimurium. 
A repeat LP was carried out on day 9 of admission (Table 2). 
Thereafter, intravenous ceftriaxone was discontinued, and 
intravenous meropenem was initiated (100 mg/kg/day q8h). The 
child became afebrile by day 14 of admission. Repeat blood, stool, 
and CSF cultures taken subsequently were sterile. An USG skull 
done on day 8 of admission revealed a normal study; however, a 
repeat study on day 47 of admission showed mild communicating 
hydrocephalus. Magnetic resonance imaging brain showed mild 
communicating hydrocephalus.
The child received antibiotics for duration of 7 weeks, and 
at discharge he was afebrile, having good oral acceptance, 
playful but carried sequelae in the form of mild communicating 
hydrocephalus. He is under close follow-up to assess for 
neurological sequelae and in view of high chances of relapse of 
the disease. All the family members were screened for carrier 
status by repeated stool cultures which were negative.
DISCUSSION
S. typhimurium is a rare cause of acute bacterial meningitis in 
immunocompetent infants worldwide including India [4-8]. In 
a report from South India, of 385 cases of pyogenic meningitis, 
Streptococcus pneumonia was the predominant pathogen [2]; 
whereas, in a series from North India, S. aureus was the most 
common pathogen among 403 culture-confirmed cases [3]. 
Salmonella as a causative organism of pyogenic meningitis was 
not reported in these two large series.
There are contentious issues regarding the management of 
Salmonella meningitis, i.e., choice of antibiotics, combinations 
in antibiotic therapy and the duration of treatment recommended. 
Antibiotics used previously either alone or in combination included 
chloramphenicol, co-trimoxazole, and ampicillin. Their use 
declined in view of changing resistance pattern and concern for 
toxicity profile. Subsequently, third-generation cephalosporin’s 
were recommended for a minimum of 3 weeks [9,10]; however, 
reports of relapses emerged even after appropriate dose and duration 
of therapy with these agents [11,12]. Around the turn of the century, 
a combination of third-generation cephalosporin with ciprofloxacin 
was recommended to be used for a minimum of 3 weeks after 
the first sterile CSF [13]. Although there has been a concern of 
arthropathy due to use of ciprofloxacin in children, it is extremely 
uncommon, and it may be used in the treatment of serious pediatric 
infections where potential benefits outweigh the risks.
In this case, the child was put on a combination of ceftriaxone 
with ciprofloxacin once the CSF culture report was available. 
Table 1: Routine hematological and biochemical parameters
Parameters At admission Day 5 of admission Day 22 of admission
Hb (g/dL) 10 6.9 10.2
Total leucocyte counts (/mm3) 10200 26700 6700
Differential leucocyte counts N66 L31 M2E1 N78 L18 M4 N60 L30 M6E4
Platelet counts (109/L) 168 192 245
Urea (mg/dL) 28 30 22
Creatinine (mg/dL) 0.6 0.7 0.6
Calcium (mg/dL) 7.1 8.0 8.3
Phosphate (mg/dL) 2.5 2.4 2.5
Sodium (mEq/L) 138 138 140
Potassium (mEq/L) 3.8 3.9 4.2
Bilirubin (mg/dL) 1.1 0.9 0.9
Total protein (g/dL) 6.1 6 6.2
Albumin (g/dL) 3.5 3.2 3.4
Globulin (g/dL) 2.6 2.8 2.8
SGOT (IU/L) 25 37 34
SGPT (IU/L) 39 44 40
SGOT: Serum glutamic-oxaloacetic transaminase, SGPT: Serum glutamic-pyruvic transaminase, Hb: Hemoglobin
Table 2: Findings of serial CSF examinations during the illness
Day of 
admission
CSF TLC CSF DLC CSF 
proteins
CSF 
glucose
CSF culture Clinical status Antibiotics
Day 1 400 cells/mm3 P85L15 200 mg/dl 19 mg/dl S. typhimurium Features of 
meningitis
D1-ceftriaxone
D3-cipro floxacin added
Day 9 150 cells/mm3 All lymphocytes 144 mg/dl 19 mg/dl S. typhimurium Partial response, 
high grade fever
Meropenem
Day 22 No cells - 40 mg/dl 33 mg/dl Sterile Afebrile, no 
meningeal signs
Meropenem
CSF: Cerebrospinal fluid, TLC: Total leukocyte count, DLC: Differential leukocyte count
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Salmonella meningitis resistant to cephalosporins, though 
uncommon, have been reported [13]. In a report of 4 cases from 
Vietnam, 2 patients required change of therapy from initial 
third generation cephalosporin combination to a combination of 
imipenem and ciprofloxacin due to slow clinical response [6]. 
Effectiveness of carbapenems in Salmonella meningitis has been 
shown in a few case reports [11,14]. Our patient had a response to the 
therapy of ceftriaxone and ciprofloxacin in terms of improvement 
in irritability and meningeal signs; however, he continued to have 
high-grade fever with leukocytosis. Despite 7 days of receiving 
these antibiotics to which isolate had shown MICs in susceptible 
range, blood culture was still positive. Therefore, his antibiotic 
was changed to meropenem as per the sensitivity report available. 
Our patient responded well to the change and fever subsided after 
1 week and repeat cultures on day 22 (2 weeks after changing 
to meropenem) came out sterile. Meropenem was continued for 
another 5 weeks to prevent any relapse.
Salmonella meningitis in infants has a wide spectrum of morbidity 
including both acute complications and long-term neurological 
sequelae. Acute complications such as hydrocephalus, subdural 
collection, cerebral infarction, ventriculitis, and intracranial abscess 
were reported in a high proportion of patients by Wu et al. [5]. In 
long-term follow-up, language disorders (52%), motor disability 
(48%), intelligence quotient <80 (43%), epilepsy (33%), sensory 
neural hearing loss (17%), visual deficits (10%), microcephaly (5%), 
and hydrocephalus (5%) were reported in the same study [5]. The 
mortality rates are significant (13-18%) even in otherwise healthy 
infants [5,7]. Our patient developed mild non-communicating 
hydrocephalus despite otherwise favorable clinical response. He is 
under close follow-up to look for any long-term sequelae.
CONCLUSION
S. typhimurium meningitis is a rare illness, associated with high 
morbidity and mortality rates. The management is challenging 
and requires prolonged therapy with appropriate antibiotics. 
A follow-up plan for developmental assessment is essential.
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